Protecting Innovation

Biotechnology innovations is helping Maryland patients access the cures and advancements in treatment they need every day.

  • Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases.
  • There are currently more than 250 biotechnology health care products and vaccines available to Maryland patients, many for previously untreatable diseases.

The biotechnology industry is a critical jobs creator in Maryland.

  • The biotechnology industry employs more than 41,000 Marylanders in good, high paying jobs and invests billions in the state annually.
  • Maryland is ranked #3 in the country in innovation and entrepreneurship, according to the U.S. Chamber of Commerce. Few states rival Maryland’s combination of a superior workforce, technological prowess, market access, and tech-centered policy incentives.

Protecting the innovation economy requires action. Lawmakers in Annapolis should take steps to protect patient access to care and Maryland’s strong innovative spirit.

  • Over 1,000 Marylanders have already signed a petition urging Annapolis to focus only on legislation that protects patients and grows Maryland’s innovative business environment.

The Maryland Tech Council supports health policies that are patient-centered, holistic, and promote patient access to cures.

  • The Maryland Tech Council advocates for policies that will bring new treatments to Maryland patients with serious medical conditions, promote innovation, and improve patient access.

Misguided drug pricing transparency legislation will harm patient access to care, stifle investment in Maryland, and do nothing to address the price consumers pay for medicine.

  • In 2017, Maryland passed drug price transparency legislation. Additional, heavyhanded drug pricing legislation risks undermining competition, disrupting product availability and stifling investment in the Maryland innovation economy.


Protecting Innovation Protects Patients and Our Economy
Read more about MTC's take on Bill SB1188 in the Baltimore Business Journal
March 30, 2018

Innovation is at the heart of Maryland’s economy and the wellbeing of patients in our state. New, groundbreaking cures and treatments save and extend the lives of patients, pushing the bounds of modern medicine, for the benefit of all. Innovative companies are able to leverage Maryland’s combination of technology know-how, business-friendly climate, and highly-educated, highly-skilled workforce to produce these cures and provide hundreds of thousands of Marylanders with well-paying jobs.

However, despite all this, the Maryland General Assembly is currently debating drug pricing legislation that would threaten the innovative potential that makes these benefits possible. New regulations, SB 1023/HB 1194, would create a government-controlled commission with broad leeway to influence drug prices and increase burdensome reporting requirements adding yet another layer of complexity to drug manufacturing.

Click here to
Let's Bring 5G to Maryland
Read more about MTC's take on Bill SB1188 in the Baltimore Business Journal
March 2, 2018

We’re for new rules for the new economy…

We’re the most Innovative State in the Nation.

We have around 12,000 IT companies – second only to Silicon Valley.

We’re the cyber security capital of the United States, home to the National Security Agency, the U.S. Cyber Command and the National Cybersecurity Center of Excellence, and around 1,200 cyber security companies.

Our workforce is extraordinary – with the highest concentration of engineers and scientists anywhere in the country, and we rank second in the concentration of STEM employment.

I could go on and on.

Simply put, our tech sector is strong. We’re competing – and leading – regionally, nationally and globally in the new digital economy.

All Marylanders should be proud of our position as a technology leader.

If want to remain at the top of these rankings, we need smart public policies. That’s why we support Senate Bill 1188.

Strong, reliable and fast mobile broadband service is necessary to connect everything in an increasingly connected world – from smartphones and tables to autonomous vehicles and diagnostic medical equipment, and so much more.  This legislation will make help speed up the installation of the infrastructure necessary to bring 5G mobile broadband service to Marylanders.

Known as small cells, this equipment can be affixed to street lights, utility poles or buildings to help provide mobile broadband coverage. This equipment is needed to meet explosive growth in mobile data usage. Plus, small cells are integral to preparing for superfast 5G speeds that soon will be the norm.

We look forward to working with each of you to win passage of this critical infrastructure legislation and get it to Gov. Hogan’s desk this session.

Maryland Legislators Should Take Steps to Protect Maryland Jobs, the Innovation Economy
Maryland Tech Council Hosts Patient Advocacy Summit on Importance of Access to Innovative Treatments
January 18, 2018

The Maryland Tech Council is hosting a summit, featuring patient and physician advocates, legislators, and industry representatives, to hear from advocates across the state about the importance of access to innovative treatments and the patient advocacy priorities for the 2018 legislative session.

As Maryland legislators consider new legislative proposals, including potentially onerous drug pricing legislation, the Maryland Tech Council urges legislators to advance the principles that make our state great: encouraging competition to improve patient access to care, stabilizing existing drug product availability, and maintaining investment in the Maryland innovation economy.

Biotechnology innovation helps Maryland patients access cures and advancements in treatments that they need. It also creates jobs for Marylanders – the biotechnology industry employs more than 41,000 Marylanders in high-paying jobs. It’s time for Maryland legislators to do their job to keep our innovation economy rolling.

We urge all Maryland legislators to take steps to protect vital life sciences industry jobs in Maryland and encourage continued investment in the innovative cures of tomorrow.